Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways

Indian Journal of Dental Research

Volumn 20, Issue 2, 2009, Pages 141-149

  Le, Xuan ^a   Laflamme, Claude ^a   Rouabhia, Mahmoud ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Bone; IL 6; MMPs; Osteoblasts; Osteoprotegerin; Porphyromonas gingivalis; RANKL; TIMPs

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MMP2 PROTEIN, HUMAN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; COMPARATIVE STUDY; DOWN REGULATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; OSTEOBLAST; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; TUMOR CELL LINE;

BONE RESORPTION; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; COLORING AGENTS; DOWN-REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOBLASTS; OSTEOPROTEGERIN; PORPHYROMONAS GINGIVALIS; RANK LIGAND; TETRAZOLIUM SALTS; THIAZOLES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 67949124707     PISSN: 09709290     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0970-9290.52884     Document Type: Article

References (34)

1. Papapanou PN. Epidemiology of periodontal diseases: An update. J Int Acad Periodontol 1999;1:110-6.
2. Lamont RJ, Jenkinson HF. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol 2000; 15:341-9.
3. Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999;20:168-238.
4. Curtis MA, Aduse-Opoku J, Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 2001;12:192-216.
5. Imamura T. The role of gingipains in the pathogenesis of periodontal diseases. J Periodontol 2003;74:111-8.
6. Cutler CW, Kalmar JR, Genco CA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol 1995;3:45-51.
7. Noiri Y, Ozaki K, Nakae H, Matsuo T, Ebisu S. An immunohistochemical study on the localization of Porphyromonas gingivalis, Campylobacter rectus and Actinomyces viscosus in human periodontal pockets. J Periodontal Res 1997;32:598-607.
8. Hayashi S, Yamane T, Miyamoto A, Hemmi H, Tagaya H, Tanio Y, et al. Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol 1998;76:911-22.
9. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-4.
10. Chen T, Feng X. Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors. Assay Drug Dev Technol 2007;4:473-82.
11. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25.
12. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-7.
13. Rouabhia M, Deslauriers N. Production and characterization of an in vitro engineered human oral mucosa. Biochem Cell Biol 2002;80:189-95.
14. Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 1999;67:2841-6.
15. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4.
16. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr. Matrix metalloproteinases: Pathways of induction by bioactive molecules. Heart Fail Rev 2004; 9:53-61.
17. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 2002;70:3143-8.
18. Loomer PM, Ellen RP, Tenenbaum HC. Effects of Porphyromonas gingivalis 2561 extracts on osteogenic and osteoclastic cell function in co-culture. J Periodontol 1998;69:1263-70.
19. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodontal Res 1991;26:213-7.
20. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL. Effect of blockade of tumor necrosis factor-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 2007;22:724-9.
21. Knudsen S, Harslof T, Husted LB, Carstens M, Stenkjaer L, Langdahl BL. The effect of interleukin-1alpha polymorphisms on bone mineral density and the risk of vertebral fractures. Calcif Tissue Int 2007;80:21-30.
22. Mori K, Le Goff B, Berreur M, Riet A, Moreau A, Blanchard F, et al . Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. J Pathol 2007;211:555-62.
23. Okahashi N, Inaba H, Nakagawa I, Yamamura T, Kuboniwa M, Nakayama K, et al. Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway. Infect Immun 2004;72:1706-14.
24. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-84.
25. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-8.
26. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-60.
27. Makela M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: Cellular origin and relationship to periodontal status. J Dent Res 1994;73:1397-406.
28. Ding Y, Uitto VJ, Haapasalo M, Lounatmaa K, Konttinen YT, Salo T, et al Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J Dent Res 1996;75:1986-93.
29. Miyajima S, Akaike T, Matsumoto K, Okamoto T, Yoshitake J, Hayashida K, et al . Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 2001;31:271-81.
30. Chang YC, Chu SC, Yang SF, Hsieh YS, Yang LC, Huang FM. Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1a and Porphyromonas gingivalis in human osteosarcoma cells. J Periodontal Res 2004;39:168-74.
31. Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, et al. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 2004;39:300-7.
32. Andrian E, Mostefaoui Y, Rouabhia M, Grenier D. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J Cell Physiol 2007;211:56-62.
33. Zhou J, Windsor LJ. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases. J Periodontal Res 2006;41:47-54.
34. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270:5331-8.